OptiNose Files 2024 Annual Report Amendment
| Field | Detail |
|---|---|
| Company | Optinose, Inc. |
| Form Type | 10-K/A |
| Filed Date | Apr 30, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: amendment, annual-report, pharmaceuticals
TL;DR
OptiNose filed its 2024 10-K amendment. All good.
AI Summary
OptiNose, Inc. filed an amendment (10-K/A) to its annual report for the fiscal year ended December 31, 2024. The company, incorporated in Delaware with its principal executive offices in Yardley, Pennsylvania, operates in the pharmaceutical preparations industry. The filing was made on April 30, 2025, under SEC file number 001-38241.
Why It Matters
This amendment provides updated financial and operational information for OptiNose, Inc. for the 2024 fiscal year, which is crucial for investors and stakeholders to assess the company's performance and outlook.
Risk Assessment
Risk Level: low — This filing is an amendment to a standard annual report and does not appear to contain significant new negative information.
Key Numbers
- 20241231 — Fiscal Year End (The period covered by the annual report.)
- 20250430 — Filing Date (The date the amendment was submitted to the SEC.)
Key Players & Entities
- OptiNose, Inc. (company) — Registrant
- Delaware (company) — State of incorporation
- Yardley, Pennsylvania (company) — Principal executive offices location
- 267-364-3500 (dollar_amount) — Business phone number
- 001-38241 (company) — SEC file number
FAQ
What is the primary purpose of this 10-K/A filing?
This 10-K/A filing is an amendment to the annual report for the fiscal year ended December 31, 2024, for OptiNose, Inc.
What is OptiNose, Inc.'s industry?
OptiNose, Inc. is in the Pharmaceutical Preparations industry, with SIC code 2834.
Where are OptiNose, Inc.'s principal executive offices located?
OptiNose, Inc.'s principal executive offices are located at 777 Township Line Road, Suite 300, Yardley, Pennsylvania 19067.
What is the SEC file number for OptiNose, Inc.?
The SEC file number for OptiNose, Inc. is 001-38241.
When was this amendment filed with the SEC?
This amendment (10-K/A) was filed as of April 30, 2025.
Filing Details
This Form 10-K/A (Form 10-K/A) was filed with the SEC on April 30, 2025 regarding OptiNose, Inc..